119 related articles for article (PubMed ID: 19338767)
1. Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA directed against malaria histone deacetylase.
Sriwilaijaroen N; Boonma S; Attasart P; Pothikasikorn J; Panyim S; Noonpakdee W
Biochem Biophys Res Commun; 2009 Apr; 381(2):144-7. PubMed ID: 19338767
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA nanoparticle against malaria topoisomerase II.
Attasart P; Boonma S; Sunintaboon P; Tanwilai D; Pothikasikorn J; Noonpakdee WT
Exp Parasitol; 2016 May; 164():84-90. PubMed ID: 26953249
[TBL] [Abstract][Full Text] [Related]
3. PfMyb1, a Plasmodium falciparum transcription factor, is required for intra-erythrocytic growth and controls key genes for cell cycle regulation.
Gissot M; Briquet S; Refour P; Boschet C; Vaquero C
J Mol Biol; 2005 Feb; 346(1):29-42. PubMed ID: 15663925
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium falciparum DNA helicase 60. dsRNA- and antibody-mediated inhibition of malaria parasite growth and downregulation of its enzyme activities by DNA-interacting compounds.
Pradhan A; Tuteja R
FEBS J; 2006 Aug; 273(15):3545-56. PubMed ID: 16884495
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy.
Mukherjee P; Pradhan A; Shah F; Tekwani BL; Avery MA
Bioorg Med Chem; 2008 May; 16(9):5254-65. PubMed ID: 18362073
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth.
Prusty D; Mehra P; Srivastava S; Shivange AV; Gupta A; Roy N; Dhar SK
FEMS Microbiol Lett; 2008 May; 282(2):266-72. PubMed ID: 18397290
[TBL] [Abstract][Full Text] [Related]
7. In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).
Kumar A; Dhar SK; Subbarao N
J Mol Model; 2018 Aug; 24(9):232. PubMed ID: 30109440
[TBL] [Abstract][Full Text] [Related]
8. A method to inhibit the growth of Plasmodium falciparum by double-stranded RNA-mediated gene silencing of helicases.
Tuteja R
Methods Mol Biol; 2010; 587():389-99. PubMed ID: 20225164
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and nuclear localization of a histone deacetylase homologue in Plasmodium falciparum.
Joshi MB; Lin DT; Chiang PH; Goldman ND; Fujioka H; Aikawa M; Syin C
Mol Biochem Parasitol; 1999 Mar; 99(1):11-9. PubMed ID: 10215020
[TBL] [Abstract][Full Text] [Related]
10. Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components.
Wheatley NC; Andrews KT; Tran TL; Lucke AJ; Reid RC; Fairlie DP
Bioorg Med Chem Lett; 2010 Dec; 20(23):7080-4. PubMed ID: 20951583
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine kinase activity in human malaria parasite Plasmodium falciparum.
Sharma A
Indian J Exp Biol; 2000 Dec; 38(12):1222-6. PubMed ID: 11411043
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum.
Patel V; Mazitschek R; Coleman B; Nguyen C; Urgaonkar S; Cortese J; Barker RH; Greenberg E; Tang W; Bradner JE; Schreiber SL; Duraisingh MT; Wirth DF; Clardy J
J Med Chem; 2009 Apr; 52(8):2185-7. PubMed ID: 19317450
[TBL] [Abstract][Full Text] [Related]
13. Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite.
Giannini G; Battistuzzi G; Vignola D
Bioorg Med Chem Lett; 2015 Feb; 25(3):459-61. PubMed ID: 25563890
[TBL] [Abstract][Full Text] [Related]
14. Simaomicin alpha: effects on the cell cycle of synchronized, cultured Plasmodium falciparum.
Ishiyama A; Otoguro K; Namatame M; Nishihara A; Furusawa T; Takahashi Y; Masuma R; Shiomi K; Omura S
J Antibiot (Tokyo); 2008 Apr; 61(4):254-7. PubMed ID: 18503207
[TBL] [Abstract][Full Text] [Related]
15. Bipolar, Dual Plasmodium falciparum helicase 45 expressed in the intraerythrocytic developmental cycle is required for parasite growth.
Pradhan A; Tuteja R
J Mol Biol; 2007 Oct; 373(2):268-81. PubMed ID: 17822710
[TBL] [Abstract][Full Text] [Related]
16. In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum.
Maerki S; Brun R; Charman SA; Dorn A; Matile H; Wittlin S
J Antimicrob Chemother; 2006 Jul; 58(1):52-8. PubMed ID: 16735432
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.
Jung SY; Zheng B; Choi YY; Soh BY; Kim SY; Park KI; Park H
Arch Pharm Res; 2009 Jun; 32(6):899-906. PubMed ID: 19557368
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
Chung YL; Lee MY; Pui NN
Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
[TBL] [Abstract][Full Text] [Related]
19. [Plasmodium falciparum: antimalarial activities of antisense oligodeoxyribonucleotides targeted to histidine-rich protein genes in vitro].
Yu XB; Fang JM; Luo SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(4):200-3. PubMed ID: 12567657
[TBL] [Abstract][Full Text] [Related]
20. Potent antimalarial activity of histone deacetylase inhibitor analogues.
Andrews KT; Tran TN; Lucke AJ; Kahnberg P; Le GT; Boyle GM; Gardiner DL; Skinner-Adams TS; Fairlie DP
Antimicrob Agents Chemother; 2008 Apr; 52(4):1454-61. PubMed ID: 18212103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
